325 related articles for article (PubMed ID: 17031467)
41. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
[TBL] [Abstract][Full Text] [Related]
42. Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer.
Osaki T; Saito H; Yoshikawa T; Matsumoto S; Tatebe S; Tsujitani S; Ikeguchi M
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):382-7. PubMed ID: 17255258
[TBL] [Abstract][Full Text] [Related]
43. Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion.
Montes CL; Chapoval AI; Nelson J; Orhue V; Zhang X; Schulze DH; Strome SE; Gastman BR
Cancer Res; 2008 Feb; 68(3):870-9. PubMed ID: 18245489
[TBL] [Abstract][Full Text] [Related]
44. MHC class I antigens and immune surveillance in transformed cells.
Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
[TBL] [Abstract][Full Text] [Related]
45. Possible key role of granzyme B in keratoacanthoma regression.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I
Med Hypotheses; 2006; 66(6):1129-32. PubMed ID: 16497444
[TBL] [Abstract][Full Text] [Related]
46. Tumor-derived soluble MICs impair CD3(+)CD56(+) NKT-like cell cytotoxicity in cancer patients.
Wang H; Yang D; Xu W; Wang Y; Ruan Z; Zhao T; Han J; Wu Y
Immunol Lett; 2008 Oct; 120(1-2):65-71. PubMed ID: 18672004
[TBL] [Abstract][Full Text] [Related]
47. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
48. Role of TGF-beta in immune-evasion of cancer.
Beck C; Schreiber H; Rowley D
Microsc Res Tech; 2001 Feb; 52(4):387-95. PubMed ID: 11170297
[TBL] [Abstract][Full Text] [Related]
49. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
Rouas-Freiss N; Moreau P; Menier C; LeMaoult J; Carosella ED
Semin Cancer Biol; 2007 Dec; 17(6):413-21. PubMed ID: 17881247
[TBL] [Abstract][Full Text] [Related]
50. NK cells and cancer immunosurveillance.
Waldhauer I; Steinle A
Oncogene; 2008 Oct; 27(45):5932-43. PubMed ID: 18836474
[TBL] [Abstract][Full Text] [Related]
51. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth.
Kim EY; Teh SJ; Yang J; Chow MT; Teh HS
J Immunol; 2009 Nov; 183(10):6051-7. PubMed ID: 19841176
[TBL] [Abstract][Full Text] [Related]
52. Tumor-induced death of immune cells: its mechanisms and consequences.
Whiteside TL
Semin Cancer Biol; 2002 Feb; 12(1):43-50. PubMed ID: 11926411
[TBL] [Abstract][Full Text] [Related]
53. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
[TBL] [Abstract][Full Text] [Related]
54. Brief report--human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes.
Yen BL; Chang CJ; Liu KJ; Chen YC; Hu HI; Bai CH; Yen ML
Stem Cells; 2009 Feb; 27(2):451-6. PubMed ID: 18988708
[TBL] [Abstract][Full Text] [Related]
55. Cytolytic responses: cadherins put out the fire.
Colonna M
J Exp Med; 2006 Feb; 203(2):261-4. PubMed ID: 16461342
[TBL] [Abstract][Full Text] [Related]
56. Overcoming immune resistance in the tumor microenvironment by blockade of indoleamine 2,3-dioxygenase and programmed death ligand 1.
Gajewski TF
Curr Opin Investig Drugs; 2004 Dec; 5(12):1279-83. PubMed ID: 15648949
[TBL] [Abstract][Full Text] [Related]
57. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
[TBL] [Abstract][Full Text] [Related]
58. Immune suppression in the tumor microenvironment.
Gajewski TF; Meng Y; Harlin H
J Immunother; 2006; 29(3):233-40. PubMed ID: 16699366
[TBL] [Abstract][Full Text] [Related]
59. Natural killer cells and solid tumors.
Stojanovic A; Cerwenka A
J Innate Immun; 2011; 3(4):355-64. PubMed ID: 21502747
[TBL] [Abstract][Full Text] [Related]
60. A validated mathematical model of cell-mediated immune response to tumor growth.
de Pillis LG; Radunskaya AE; Wiseman CL
Cancer Res; 2005 Sep; 65(17):7950-8. PubMed ID: 16140967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
